Aligos Therapeutics Inc
NASDAQ:ALGS
Aligos Therapeutics Inc
NASDAQ:ALGS
Price:
7.9
USD
-2.35%
Market Closed
Market Cap:
$48.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
T
|
Titan America SA
NYSE:TTAM
|
BE |
|
SMA Solar Technology AG
LSE:0NIF
|
DE |
|
Wuhan East Lake High Technology Group Co Ltd
SSE:600133
|
CN |
|
L
|
Lightwave Logic Inc
NASDAQ:LWLG
|
US |
|
Huber+Suhner AG
LSE:0QNH
|
CH |
|
Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
|
CN |
|
Singapore Press Holdings Ltd
F:SGP1
|
SG |
|
Ocumetics Technology Corp
XTSX:OTC
|
CA |
Balance Sheet
Balance Sheet Decomposition
Aligos Therapeutics Inc
Aligos Therapeutics Inc
Balance Sheet Decomposition is not available for
Aligos Therapeutics Inc
Aligos Therapeutics Inc
Balance Sheet
Aligos Therapeutics Inc
Aligos Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
24
|
70
|
220
|
187
|
81
|
136
|
37
|
18
|
|
| Cash Equivalents |
24
|
70
|
220
|
187
|
81
|
136
|
37
|
18
|
|
| Short-Term Investments |
67
|
48
|
23
|
4
|
45
|
0
|
20
|
60
|
|
| Other Current Assets |
2
|
3
|
7
|
14
|
8
|
5
|
5
|
5
|
|
| Total Current Assets |
92
|
120
|
250
|
204
|
134
|
141
|
62
|
83
|
|
| PP&E Net |
15
|
16
|
15
|
15
|
13
|
10
|
7
|
5
|
|
| PP&E Gross |
15
|
16
|
15
|
15
|
13
|
10
|
7
|
5
|
|
| Accumulated Depreciation |
0
|
2
|
4
|
7
|
10
|
11
|
12
|
13
|
|
| Long-Term Investments |
0
|
10
|
0
|
15
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
108
N/A
|
147
+36%
|
265
+81%
|
235
-11%
|
147
-38%
|
152
+3%
|
70
-54%
|
89
+26%
|
|
| Liabilities | |||||||||
| Accounts Payable |
3
|
4
|
3
|
3
|
5
|
3
|
3
|
4
|
|
| Accrued Liabilities |
4
|
9
|
18
|
27
|
18
|
17
|
16
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
9
|
9
|
11
|
4
|
3
|
3
|
|
| Total Current Liabilities |
8
|
14
|
30
|
39
|
33
|
24
|
22
|
21
|
|
| Long-Term Debt |
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
13
|
12
|
15
|
11
|
9
|
35
|
77
|
14
|
|
| Total Liabilities |
21
N/A
|
29
+40%
|
45
+55%
|
51
+12%
|
43
-15%
|
59
+39%
|
99
+67%
|
35
-65%
|
|
| Equity | |||||||||
| Common Stock |
101
|
182
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
14
|
66
|
175
|
303
|
399
|
487
|
618
|
642
|
|
| Additional Paid In Capital |
0
|
1
|
395
|
487
|
503
|
578
|
589
|
695
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Total Equity |
87
N/A
|
117
+35%
|
220
+88%
|
185
-16%
|
104
-44%
|
92
-11%
|
29
N/A
|
54
N/A
|
|
| Total Liabilities & Equity |
108
N/A
|
147
+36%
|
265
+81%
|
235
-11%
|
147
-38%
|
152
+3%
|
70
-54%
|
89
+26%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
37
|
37
|
40
|
43
|
43
|
5
|
3
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
